Return to search results.
Complete title: A Phase I, Open Label, Multi-center Study to Assess the Safety, Pharmacokinetics and Effectiveness of AGS-16C3F Monotherapy in Subjects with Renal Cell Carcinoma of Clear Cell or Papillary Histology
|Research Study Number||20121076|
|Principal Investigator||John Thompson, MD|
Research Study Description
Eligibility Criteria (must meet the following to participate in this study)
Other eligibility criteria may apply.
Kidney Cancer; Renal Cancer
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.